How common are liver enzyme increases with tigecycline use?

How common are liver enzyme increases with tigecycline use?

Liver enzyme elevations occur in roughly 3 to 5 percent of patients who receive tigecycline. The most frequent changes are modest rises in alanine aminotransferase and aspartate aminotransferase. These shifts are usually mild, asymptomatic, and return to baseline after the drug is stopped.

What proportion of elevations become clinically significant?

Serious or symptomatic liver injury remains uncommon. Fewer than 1 percent of patients in clinical trials developed enzyme levels high enough to require discontinuation or meet criteria for drug-induced liver injury. Post-marketing surveillance has recorded rare cases of acute liver failure, but these reports are too sparse to calculate a reliable frequency.

How do liver risks compare with other tetracyclines?

Tigecycline shares the tetracycline class warning for hepatotoxicity, yet its incidence of enzyme elevation is lower than minocycline and comparable to doxycycline. Unlike older tetracyclines, tigecycline does not accumulate in patients with hepatic impairment, which may reduce its overall liver risk profile.

When do enzyme changes typically appear?

Elevations are most often detected within the first week of therapy. In pooled trial data, median onset occurred around day five, with values returning toward normal within one to two weeks after the final dose.

What patient factors increase the chance of enzyme increases?

Pre-existing liver disease, concurrent hepatotoxic medications, and prolonged courses beyond two weeks appear to raise the likelihood of larger enzyme shifts. Obesity and critical illness have also been linked to higher rates in observational reports.

How should clinicians monitor liver enzymes during treatment?

Baseline testing is recommended, followed by repeat checks every three to five days while on therapy. Any rise greater than three times the upper limit of normal should prompt closer observation or discontinuation if symptoms develop.